Marc A. Grundl

Birkendorfer Str. 65
Biberach An Der Riss, BW 88397, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Identification of a NUAK1/2 Inhibitor as a Macrophage-Polarizing Compound by a Machine Learning-Based Phenotypic Cell Painting Screen.

Identification of a NUAK1/2 Inhibitor as a Macrophage-Polarizing Compound by a Machine Learning-Based Phenotypic Cell Painting Screen.

Journal: International journal of molecular sciences

Published: June 18, 2026

Insights into the Identification of iPSC- and Monocyte-Derived Macrophage-Polarizing Compounds by AI-Fueled Cell Painting Analysis Tools.

Insights into the Identification of iPSC- and Monocyte-Derived Macrophage-Polarizing Compounds by AI-Fueled Cell Painting Analysis Tools.

Journal: International journal of molecular sciences

Published: October 18, 2024

Interleukin-1 receptor-associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll-like receptors 4 and 7/8 in murine and human lungs.

Interleukin-1 receptor-associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll-like receptors 4 and 7/8 in murine and human lungs.

Journal: British journal of pharmacology

Published: January 11, 2024

Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats.

Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats.

Journal: Journal of translational medicine

Published: May 23, 2023

Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1.

Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1.

Journal: Nature communications

Published: March 02, 2023

BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis.

BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: February 07, 2023

BIreactive: Expanding the Scope of Reactivity Predictions to Propynamides.

BIreactive: Expanding the Scope of Reactivity Predictions to Propynamides.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 16, 2022

opnMe.com: a digital initiative for sharing tools with the biomedical research community.

opnMe.com: a digital initiative for sharing tools with the biomedical research community.

Journal: Nature reviews. Drug discovery

Published: April 23, 2022

Targeting Cathepsin C in PR3-ANCA Vasculitis.

Targeting Cathepsin C in PR3-ANCA Vasculitis.

Journal: Journal of the American Society of Nephrology : JASN

Published: August 20, 2021

Covalent inhibitor reactivity prediction by the electrophilicity index-in and out of scope.

Covalent inhibitor reactivity prediction by the electrophilicity index-in and out of scope.

Journal: Journal of computer-aided molecular design

Published: June 17, 2020

BIreactive: A Machine-Learning Model to Estimate Covalent Warhead Reactivity.

BIreactive: A Machine-Learning Model to Estimate Covalent Warhead Reactivity.

Journal: Journal of chemical information and modeling

Published: April 07, 2020

A Fast Ab Initio Predictor Tool for Covalent Reactivity Estimation of Acrylamides.

A Fast Ab Initio Predictor Tool for Covalent Reactivity Estimation of Acrylamides.

Journal: Journal of chemical information and modeling

Published: June 28, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026